A Crucial Step Adjunct to CT Attenuation Values In Characterizing Adrenal Masses A Prospective Observational Study At Our Institute

A Crucial Step Adjunct To CT Attenuation Values

Authors

  • Chhaya Jagat Bhatt
  • Kavita Umesh Vaishnav
  • Dharita Sandip Shah
  • Karthik Dhavala

DOI:

https://doi.org/10.70284/njirm.v5i5.791

Keywords:

Adrenal masses, Attenuation values, Washout studies

Abstract

Aim: To characterize incidentally detected adrenal masses by CT attenuation values and 15 minutes wash out characteristics at contrast-enhanced CT. Method : Prospective observational study from March 2012 -2013 was done, with all the abdominal scan evaluated for adrenal masses. Departmental protocol was followed with15 minutes delayed scan added. CT attenuation values at different phases were used to calculate absolute percentage washout (APW) and relative percentage washout (RPW). The masses with attenuation value <10HU on unenhanced scans were diagnosed as lipid rich adenomas and masses with attenuation values >10 on plain scan with APW of >60% and RPW>40% were diagnosed as lipid poor adenomas; rest being non-adenomas, metastasis if there was known malignancy. The masses were evaluated in terms of their sizes, site of involment, stastical significance (p<0.05) in attenuation values at different phases and washout studies. Results: 96 lesions were detected in 84 patients from March 2012 -2013.M:F ratios of 1.7:1, mean age being 46 years. Lipid poor adenomas (LPA) were the commonest mass followed by metastasis. 64% of patients with malignancy had adrenal metastasis while 36% had adenomas. There was no significant difference in size(p=0.23) between LPA and non-adenomas (NA) whereas statistical difference was noted in mean attenuation values on unenhanced, delayed, wash-in and wash-out values(p <0.05).There was no significant difference on enhanced scan (p=0.95),but absolute percentage washout (APW) and relative percentage washout (RPW) was statistically significant between LPA and NA (p<0.05).Conclusion: CT attenuation values, absolute and relative percentage washout values characterize the adrenal masses.[Bhatt Chh NJIRM 2014; 5(5):5-12]

References

1. Dr. Annirudh Kohli Adrenal Incidentalomas: Can we characterize them? Ind J of Radiol Imag 2006:2:163-164
2. Korobkin M, Francis IR,Kloos RT,Dunnick NR. The incident adrenal mass.Radilo Clin North Am 1996; 34:1034-1054
3. Bertherat J,Mosnier-Pudar H,Bertagna Adrenal incidentalomas. Curr Opnin Onco 2002:14:58-63.
4. Song JH, Chaudhry FS, Mayo-Smith WW.the prevalence of adrenal disease in 1049 consecutive adrenal masses in patients with no known malignancy. Am.J Roengenol 2008; 190(5):1163-1168.
5. Bovio S, Cataidi A,Reimondo G,et.al.Prevalence of adrenal incidentalomas in a contemporary computerized tomography series .J Endocrinol Invest 2006:29:298-302.
6. Oliver JW Jr,Benardino ME, Miller JI, Mansourk, Greene D,Davis WA.Isolated adrenal mass in non-small-cell bronchogenic carcinoma. Radiology1984; 153:217-21.
7. Michael A, Blake, Carmel G, Cronin and Giles W, Boland. Adrenal Imaging: Am.J Roengenol 2010; 194:1450-1460.
8. ACR Appropriateness Criteria: incidentally discovered adrenal mass. http://www.acr.org/secondary Main menu Categories/quality _safety/app_criteria/pdf/Export Panel on Urological Imaging/Incidentally discovered adrenal mass Doc7.acpx.
9. Korobkin M,Giordano,F J Brodeur,I R Francis, E S Siegelman, LE Quint,N R Dunnick,J P Heiken and H H wang.Adrenal adenomas: relationship between histologic lipid and CT & MR findings. Radiology 1996; 200:743-747.
10. Bolond GW, Lee MJ, gazelle, et al.Charaterization of adrenal masses using unenhanced CT: an analysis of the CT literature. Am.J Roengenol 1998; 171:201-204.
11. Lee MJ,Hahn PF, Papnicolau N,et al. CT distinction with attenuation coefficient, size, and observer analysis. Radiology 1991; 179:415-418.
12. Giles WL, Boland, Michael, Blake, Peter F Hahn, William W, Mayo-Smith. Incidental adrenal lesion: Principles, Techniques, and algorithms
for imaging characterization. Radiology 2008; 249(3) .
13. D H Szolar and F.H.kammerhuber. Adrenal adenomas and non adenomas: Assessment of washout at delayed contrast enhanced CT Radiology 1998; 207:369-375.
14. M. Korobkin, Fredrick J.Brodeur, Issac R. Francis,l E Quint, N.Reed Dunnick, Frank Londy. CT Attenuation washout curves of Adrenal Adenomas and Nonadenomas. Am.J Roengenol 1998; 170:747-752.
15. Szolar DH, Kammerhuber F. Quantitative CT evaluation of adrenal gland masses: A step forward in differentiation between adenomas and non adenomas. Radiology 1997; 202: 517-521.
16. Elaine M. Caoili, Melvyn Korobkin, Issac R, Richard H. Cohan, Joel F. Platt, N. Reed Dunnick, Kartik I.Raghpathi. Adrenal Masses: Characterization with Combined Unenhanced and Delayed Enhanced CT. Radiology 2002; 222:629-633.
17. Blake MA, Kalra MK, Sweeney AJ, et al. Distinguishing benign from malignant adrenal masses: Multi detector row CT protocol with 10 minutes delay. Radiology 2006; 238(2):578-585.
18. Pena CS,Boland GW,Hahn PF,Lee MJ, Muller PR. Characterization of indetermined (lipid poor) adrenal masses: use of wash out characteristic at contrast enhanced CT.Radiology 2000:217-(3),798-802
19. Lenert JT, Barnett CC Jr, Kudelka AP, et al. Evaluation and surgical resection of adrenal masses in patient with a history of extra adrenal malignancy. Surgery 2001; 130:1060-1067.
20. Lam K, Lo CY metastatic tumors of the adrenal glands: a 30 years experience in a teaching hospital. Clin Endocrinol 2002; 56:95-101.
21. B.J Vazquez, M.L. Richards, C.M. Lohse, G.B. Thompson, D.R. Farley,C.S.Grant, M. Huebner,J. Morena. Adrenalectomy Improves Outcomes of selected patients with metastatic carcinoma. World J.Surg 2012; 36:1400-1405.
22. Halefoglu AM,Bas N, Yasar A, Basak M. Differentiation of adrenal adenoma from non adenomas using CT histogram analysis method:a prospective study:Eur J Radiol 2010,73:643-651.
23. D.H. Szolar,M. Korobkin, Pia Resttner, Andrea Berghold,Thomas Bauernhofer, HaraldTrummer,Helmut Schoellnast, Klaus W. Preidler, &Hellmuth Samonigg. Adrenocortical Carcinoma and adrenal pheochromocytomas: Mass and Enhancement Loss Evaluation on Delayed Contrast-enhanced CT. Radiology 2005; 234:479-485.
24. Blake MA, Kalre MK. and Sweeney AT et al. Distinguishing benign from malignant adrenal masses: Multi detector row CT protocol with 10 minutes delay. Radiology 2005; 238:578-585.
25. Johnson PT, Horton KM, Fishman EK. Adrenal mass imaging with Multi detector CT: Pathologic conditions, pearls and pitfalls. Radiographic 2009; 29:1333-1351.
26. Pailing MR, Williamson BR. Adrenal involvement in Non-Hodgkin’s lymphoma. Am J Roentgenol 1983; 141(2): 303-305.
27. Guo YK, Yang ZG, Deng YP, Min PQ, Yin LL, Hu J, Zhang XC,Chen TW. Addison’s disease due to adrenal tuberculosis: Contrast enhanced CT features and clinical duration correlation. Eur J Radiol 2007; 62(1):126-131.
28. Wilms GE,Baert AL,Kint EJ, Pringot JH, Goddeeris PG. Computed tomographic findings in bilateral adrenal tuberculosis. Radiology 1983;146:729.
29. Morgan HE,Austin JH,Follet Da. Bilateral adrenal enlargement in addison’s disease caused by tuberculosis: nephrotomographic demonstration. Radiology 1975;115:357.
30. William W, Mayo-Smith, Giles W Boland, Richard B Noto, Michael J.Lee. State-of-Art-Adrenal Imaging. Radiographics 2001; 21:995-1012.

Downloads

Published

2018-01-05

How to Cite

Bhatt, C. J., Vaishnav, K. U., Shah, D. S., & Dhavala, K. (2018). A Crucial Step Adjunct to CT Attenuation Values In Characterizing Adrenal Masses A Prospective Observational Study At Our Institute: A Crucial Step Adjunct To CT Attenuation Values. National Journal of Integrated Research in Medicine, 5(5), 5–12. https://doi.org/10.70284/njirm.v5i5.791

Issue

Section

Original Articles

Most read articles by the same author(s)